vs
Side-by-side financial comparison of APTARGROUP, INC. (ATR) and Kimco Realty (KIM). Click either name above to swap in a different company.
APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $558.0M, roughly 1.7× Kimco Realty). Kimco Realty runs the higher net margin — 29.8% vs 7.7%, a 22.1% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs 4.0%). Over the past eight quarters, Kimco Realty's revenue compounded faster (5.6% CAGR vs 2.6%).
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
Kimco Realty Corporation, headquartered in Jericho, New York, is a real estate investment trust that invests in shopping centers.
ATR vs KIM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $962.7M | $558.0M |
| Net Profit | $74.3M | $166.3M |
| Gross Margin | — | — |
| Operating Margin | 11.0% | 37.2% |
| Net Margin | 7.7% | 29.8% |
| Revenue YoY | 13.5% | 4.0% |
| Net Profit YoY | -26.4% | 23.7% |
| EPS (diluted) | $1.13 | $0.46 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $558.0M | ||
| Q4 25 | $962.7M | $542.5M | ||
| Q3 25 | $961.1M | $535.9M | ||
| Q2 25 | $966.0M | $525.2M | ||
| Q1 25 | $887.3M | $536.6M | ||
| Q4 24 | $848.1M | $525.4M | ||
| Q3 24 | $909.3M | $507.6M | ||
| Q2 24 | $910.1M | $500.2M |
| Q1 26 | — | $166.3M | ||
| Q4 25 | $74.3M | $151.2M | ||
| Q3 25 | $127.9M | $137.8M | ||
| Q2 25 | $111.7M | $163.0M | ||
| Q1 25 | $78.8M | $132.8M | ||
| Q4 24 | $100.9M | $166.0M | ||
| Q3 24 | $100.0M | $136.0M | ||
| Q2 24 | $90.5M | $119.7M |
| Q1 26 | — | 37.2% | ||
| Q4 25 | 11.0% | 36.4% | ||
| Q3 25 | 14.2% | 34.9% | ||
| Q2 25 | 14.9% | 39.2% | ||
| Q1 25 | 12.8% | 33.6% | ||
| Q4 24 | 14.2% | 31.7% | ||
| Q3 24 | 15.2% | 33.7% | ||
| Q2 24 | 13.8% | 32.1% |
| Q1 26 | — | 29.8% | ||
| Q4 25 | 7.7% | 27.9% | ||
| Q3 25 | 13.3% | 25.7% | ||
| Q2 25 | 11.6% | 31.0% | ||
| Q1 25 | 8.9% | 24.8% | ||
| Q4 24 | 11.9% | 31.6% | ||
| Q3 24 | 11.0% | 26.8% | ||
| Q2 24 | 9.9% | 23.9% |
| Q1 26 | — | $0.46 | ||
| Q4 25 | $1.13 | — | ||
| Q3 25 | $1.92 | — | ||
| Q2 25 | $1.67 | — | ||
| Q1 25 | $1.17 | — | ||
| Q4 24 | $1.48 | — | ||
| Q3 24 | $1.48 | — | ||
| Q2 24 | $1.34 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $409.5M | — |
| Total DebtLower is stronger | $1.1B | — |
| Stockholders' EquityBook value | $2.7B | $10.4B |
| Total Assets | $5.3B | $19.6B |
| Debt / EquityLower = less leverage | 0.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $409.5M | $211.6M | ||
| Q3 25 | $264.8M | $159.3M | ||
| Q2 25 | $169.8M | $226.6M | ||
| Q1 25 | $136.8M | $131.3M | ||
| Q4 24 | $226.2M | $688.6M | ||
| Q3 24 | $327.9M | $789.0M | ||
| Q2 24 | $223.9M | $126.4M |
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $7.7B | ||
| Q3 25 | $546.0M | — | ||
| Q2 25 | $535.1M | — | ||
| Q1 25 | $561.2M | — | ||
| Q4 24 | $688.1M | $8.0B | ||
| Q3 24 | $822.7M | — | ||
| Q2 24 | $681.5M | — |
| Q1 26 | — | $10.4B | ||
| Q4 25 | $2.7B | $10.4B | ||
| Q3 25 | $2.8B | $10.5B | ||
| Q2 25 | $2.7B | $10.5B | ||
| Q1 25 | $2.5B | $10.6B | ||
| Q4 24 | $2.5B | $10.7B | ||
| Q3 24 | $2.5B | $10.5B | ||
| Q2 24 | $2.4B | $10.6B |
| Q1 26 | — | $19.6B | ||
| Q4 25 | $5.3B | $19.7B | ||
| Q3 25 | $5.1B | $19.9B | ||
| Q2 25 | $4.9B | $19.8B | ||
| Q1 25 | $4.5B | $19.7B | ||
| Q4 24 | $4.4B | $20.3B | ||
| Q3 24 | $4.6B | $20.1B | ||
| Q2 24 | $4.5B | $19.5B |
| Q1 26 | — | — | ||
| Q4 25 | 0.43× | 0.74× | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.28× | 0.75× | ||
| Q3 24 | 0.32× | — | ||
| Q2 24 | 0.28× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.7M | — |
| Free Cash FlowOCF − Capex | $96.9M | — |
| FCF MarginFCF / Revenue | 10.1% | — |
| Capex IntensityCapex / Revenue | 9.0% | — |
| Cash ConversionOCF / Net Profit | 2.47× | — |
| TTM Free Cash FlowTrailing 4 quarters | $299.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $183.7M | $258.4M | ||
| Q3 25 | $177.6M | $332.4M | ||
| Q2 25 | $126.0M | $305.4M | ||
| Q1 25 | $82.7M | $223.8M | ||
| Q4 24 | $178.2M | $239.5M | ||
| Q3 24 | $229.3M | $295.9M | ||
| Q2 24 | $143.6M | $294.1M |
| Q1 26 | — | — | ||
| Q4 25 | $96.9M | — | ||
| Q3 25 | $114.3M | — | ||
| Q2 25 | $62.5M | — | ||
| Q1 25 | $25.9M | $205.4M | ||
| Q4 24 | $112.2M | — | ||
| Q3 24 | $162.7M | — | ||
| Q2 24 | $75.4M | — |
| Q1 26 | — | — | ||
| Q4 25 | 10.1% | — | ||
| Q3 25 | 11.9% | — | ||
| Q2 25 | 6.5% | — | ||
| Q1 25 | 2.9% | 38.3% | ||
| Q4 24 | 13.2% | — | ||
| Q3 24 | 17.9% | — | ||
| Q2 24 | 8.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 9.0% | 0.0% | ||
| Q3 25 | 6.6% | 0.0% | ||
| Q2 25 | 6.6% | 0.0% | ||
| Q1 25 | 6.4% | 3.4% | ||
| Q4 24 | 7.8% | — | ||
| Q3 24 | 7.3% | — | ||
| Q2 24 | 7.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 2.47× | 1.71× | ||
| Q3 25 | 1.39× | 2.41× | ||
| Q2 25 | 1.13× | 1.87× | ||
| Q1 25 | 1.05× | 1.69× | ||
| Q4 24 | 1.77× | 1.44× | ||
| Q3 24 | 2.29× | 2.18× | ||
| Q2 24 | 1.59× | 2.46× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
KIM
| Revenues from rental properties, net | $552.8M | 99% |
| Management and other fee income | $5.2M | 1% |
